Enhanced And Highly Specific Delivery Of Small Interfering RNA And Oligonucleotides As Therapeutics For Gene Silencing
Funder
National Health and Medical Research Council
Funding Amount
$311,860.00
Summary
This proposal aims to develop glyco-nanocarriers for the efficient and specific delivery of siRNA/oligonucleotides to treat liver diseases. Complex glycopolymer architectures developed here will protect desired genes from enzymatic degradation and will deliver the gene to the liver specifically for therapy, hence providing a solution towards nucleic acid therapy.
Novel antimicrobial surface coatings for Cochlear implants. The objective of this project is to develop new antimicrobial coatings for materials used to manufacture biomedical devices. Infection associated with the use of biomaterials such as biomedical implants, catheters and orthopaedic prostheses is a major barrier to the use of these devices. The coatings that the project plans to develop are based on novel antimicrobials which have been shown to prevent adhesion and colonisation of biomater ....Novel antimicrobial surface coatings for Cochlear implants. The objective of this project is to develop new antimicrobial coatings for materials used to manufacture biomedical devices. Infection associated with the use of biomaterials such as biomedical implants, catheters and orthopaedic prostheses is a major barrier to the use of these devices. The coatings that the project plans to develop are based on novel antimicrobials which have been shown to prevent adhesion and colonisation of biomaterials by bacteria in vivo. This strategy has the potential to prevent device-related infections and revolutionise the biomaterials industry.Read moreRead less
Novel antimicrobial surface coatings for biomedical applications. There are currently no effective biomaterial coatings to reduce device related infections. Such materials are needed to address the high rates of infection that can occur. The melimine technology proposed here has the potential to significantly reduce rates of infection, reduce health care costs and advantage the Australian biomaterials industry.
Antimicrobial contact lens cases. Contamination of contact lens cases is now recognised as a major risk factor driving the incidence of corneal infections during contact lens wear. This project will develop novel antimicrobial materials for manufacture of lens cases for the prevention of infections associated with contact lens wear.
Development of a multicomponent delivery system for oligonucleotides. Gene therapy has the ability to prevent faulty genes from causing disease, however the ability to deliver genetic material into specific cells remains a major barrier. Our research will overcome this hurdle by generating systems that are superior to existing technologies.